Company Overview
Snapshot
Founded in September 2024 by Rom Zilberberg and Omri Saar, Apex Bio operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing innovative therapeutics for neurodegenerative diseases.
Business overview
Apex Bio is a biotech startup dedicated to advancing brain health through novel therapeutic solutions. The company is developing a disease-modifying platform specifically designed to diagnose and prevent Alzheimer’s disease years before the onset of symptoms. Operating within the Health Tech & Life Sciences sector, Apex Bio targets the pharmaceutical and medical biotechnology industries with its B2B business model.
Log in to access full profile ›Company Intelligence Q&A
- When was Apex Bio founded?
- Apex Bio was founded in September 2024.
- Who are the founders of Apex Bio?
- Apex Bio was co-founded by Rom Zilberberg, who serves as CEO, and Omri Saar, who is the COO.
- What is Apex Bio's primary focus?
- Apex Bio is focused on developing innovative therapeutics for neurodegenerative diseases, particularly a novel platform for diagnosing and preventing Alzheimer’s disease.
- What is the current employee size of Apex Bio?
- Apex Bio currently has 1–10 employees.
- What is Apex Bio's business model?
- Apex Bio operates with a B2B business model.